Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
16.58
+1.68
+(11.28%)
As of 2:51:49 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-11,516
-5,824
-10,543
Investing Cash Flow
-103
--
-1,000
Financing Cash Flow
83,005
--
225
End Cash Position
82,277
9,735
15,559
Issuance of Capital Stock
85,169
--
225
Free Cash Flow
-11,619
-5,824
-10,543
12/31/2022 - 2/13/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAZE Maze Therapeutics, Inc.
12.47
-0.72%
MTSR Metsera, Inc.
31.58
-1.03%
SION Sionna Therapeutics, Inc.
20.83
+4.32%
SEPN Septerna, Inc.
6.14
+10.63%
SRNE Sorrento Therapeutics, Inc.
0.0005
0.00%
CELU Celularity Inc.
1.8000
-4.26%
ANAB AnaptysBio, Inc.
19.13
-2.45%
STOK Stoke Therapeutics, Inc.
8.81
-5.27%
VERA Vera Therapeutics, Inc.
29.73
+0.71%
CRBP Corbus Pharmaceuticals Holdings, Inc.
8.03
+2.95%